ACROBiosystems Stock Hits Day Low of CNY 47.21 Amid Price Pressure

ACROBiosystems Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 9.98% to touch an intraday low of CNY 47.21. This performance starkly contrasts with the broader market, as the China Shanghai Composite index fell by only 3.05% during the same period. Over the past week, ACROBiosystems has seen a decrease of 4.45%, while its one-month performance remains positive at 25.45%. However, the stock has struggled over the longer term, with a year-to-date decline of 10.46% and a three-year performance down by 15.07%. Despite these challenges, the company reported a notable operating cash flow of CNY 530.69 million, alongside a strong debtors turnover ratio of 7.94 times. With a return on equity of 6.17% and a price-to-book ratio of 1.71, ACROBiosystems maintains a fair valuation. However, the stock's performance has lagged behind the market, generating a negative return of 32.82% over the past year compared to the China Shanghai Composite's 16.83% gain.